bioRxivBiochemistry
Structural insights into plasticity and discovery of remdesivir metabolite GS-441524 binding in SARS-CoV-2 macrodomain
X. Ni, M. Schroeder, V. Olieric, M. E. Sharpe, V. Olmos, E. Proschak, D. Merk, S. Knapp, A. Chaikuad
Abstract
The nsP3 macrodomain is a conserved protein interaction module that plays essential regulatory roles in host immune response by recognizing and removing posttranslational ADP-ribosylation sites during SARS-CoV-2 infection. Thus, targeting this protein domain may offer a therapeutic strategy to combat the current and future virus pandemics. To assist inhibitor development efforts, we report here a comprehensive set of macrodomain crystal structures complexed with diverse naturally-occurring nucleotides, small molecules as well as nucleotide analogues including GS-441524 and its phosphorylated analogue, active metabolites of remdesivir. The presented data strengthen our understanding of the SARS-CoV-2 macrodomain structural plasticity and it provides chemical starting points for future inhibitor development.
- organism: virus
- assay: structural biology
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and X-ray diffraction at room temperature
G. J. Correy, D. W. Kneller, … J. S. Fraser·bioRxiv·Feb 7, 2022
- Design, Synthesis and Evaluation of Inhibitors of the SARS-CoV-2 nsp3 Macrodomain
L. M. Sherrill, E. E. Joya, … D. V. Ferraris·bioRxiv·Feb 27, 2022
- Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
M. Schuller, G. J. Correy, … Smi·bioRxiv·Nov 24, 2020
- Molecular Basis for ADP-ribose Binding to the Macro-X Domain of SARS-CoV-2 Nsp3
D. Frick, R. S. Virdi, … N. R. Silvaggi·bioRxiv·Mar 31, 2020
- Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2
S. Gahbauer, G. J. Correy, … J. S. Fraser·bioRxiv·Jun 27, 2022
- The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase
Y. M. O. Alhammad, M. M. Kashipathy, … A. R. Fehr·bioRxiv·May 11, 2020